Guoping Da promoted to partner at Jones Day
22 December 2020
Guoping Da has been promoted to partner at Jones Day in Shanghai effective January 1, 2021. Da is an IP litigator and counselor who represents multinational companies in IP enforcement and infringement actions in the United States and China. These representations have involved a broad range of technologies such as biotechnology, pharmaceuticals, animal health products, optics, computer hardware and software, and vehicle telematics. She also has extensive experience in the area of trade secrets, and she published an article regarding strategies for trade secret protection in China.
Her recent experience includes: Incyte’s strategic collaboration and license agreement with Innovent for the China rights of certain clinical stage pharmaceutical candidates; Incyte’s sublicense out to Zai Lab of certain intellectual property rights in China to an anti-PD1 molecule; and Huadong Medicine’s subscription of Series B preferred shares of R2 Dermatology and the distribution agreement between R2 and Huadong regarding a medical device product.
Da also assists multinational companies on compliance and corruption matters. Her experience includes advising clients on Foreign Corrupt Practices Act (FCPA) issues and conducting related investigations, providing compliance training for clients operating in China, and conducting anticorruption due diligence for inbound investment.
Her Ph.D. thesis focused on structure determination and function characterization of gene regulatory proteins, including histone deacetylases and histone demethylases. As such, she is familiar with a broad range of molecular, biochemical, and biophysical research tools centred around X-ray crystallography and structure-based drug design.
